Drug combo 'game changer' for resistant TB

• Autores: Andy Coghlan
• Localización: New scientist, ISSN 0262-4079, Nº. 2979, 2014, pág. 15
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The first new medication in half a century for the widespread treatment of tuberculosis (TB) has also shown the potential to cure drug-resistant TB. Multidrug-resistant TB (MDR TB) accounts for nearly 4% of new TB cases globally and is undermining attempts to stamp out ordinary TB because treatments are so expensive they sap funds. Preliminary results from a trial of a triple-drug combination called PaMZ, presented at the annual International AIDS Conference in Melbourne Australia, raise the prospect of treating all people with TB with the same inexpensive drugs. This could be a game changer, says Mel Spigelman of the TB Alliance, a New York-based non-profit group that collaborated with universities in South Africa to carry out the trial.